Impact of Nodular Calcifications in the Aortic Annulus and Left Ventricular Outflow Tract on TAVI Outcome with New-Generation Devices.

computational simulation device success nodular calcification paravalvular leak transcatheter aortic valve implantation

Journal

Reviews in cardiovascular medicine
ISSN: 1530-6550
Titre abrégé: Rev Cardiovasc Med
Pays: Singapore
ID NLM: 100960007

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 01 05 2022
revised: 10 07 2022
accepted: 31 07 2022
medline: 25 10 2022
pubmed: 25 10 2022
entrez: 30 7 2024
Statut: epublish

Résumé

The impact of nodular calcifications in left ventricular outlow tract (LVOT) and aortic annulus on the procedural outcome of transcatheter aortic valve implantation (TAVI) with new-generation devices is yet to be elucidated. Similarly, computational simulations may provide a novel insight into the biomechanical features of TAVI devices and their interaction with nodular calcifications. This retrospective single-center study included 232 patients submitted to TAVI with Evolut-R (53.4%), Portico (33.6%) and Lotus (13.0%) devices with available preoperative computed tomography (CT) angiography and evidence of nodular calcifications in aortic annulus and/or LVOT. Calcification severity was defined At least moderate calcifications were found in 123 (53.0%) patients, with no sex differences. Among the At least moderate nodular calcifications in the annulus/LVOT region significantly affected TAVI outcome, as they were independent predictors of device success. Lotus and Portico seemed to perform better than Evolut-R as for device success and

Sections du résumé

Background UNASSIGNED
The impact of nodular calcifications in left ventricular outlow tract (LVOT) and aortic annulus on the procedural outcome of transcatheter aortic valve implantation (TAVI) with new-generation devices is yet to be elucidated. Similarly, computational simulations may provide a novel insight into the biomechanical features of TAVI devices and their interaction with nodular calcifications.
Methods UNASSIGNED
This retrospective single-center study included 232 patients submitted to TAVI with Evolut-R (53.4%), Portico (33.6%) and Lotus (13.0%) devices with available preoperative computed tomography (CT) angiography and evidence of nodular calcifications in aortic annulus and/or LVOT. Calcification severity was defined
Results UNASSIGNED
At least moderate calcifications were found in 123 (53.0%) patients, with no sex differences. Among the
Conclusions UNASSIGNED
At least moderate nodular calcifications in the annulus/LVOT region significantly affected TAVI outcome, as they were independent predictors of device success. Lotus and Portico seemed to perform better than Evolut-R as for device success and

Identifiants

pubmed: 39076178
doi: 10.31083/j.rcm2311358
pii: S1530-6550(22)00652-4
pmc: PMC11269076
doi:

Types de publication

Journal Article

Langues

eng

Pagination

358

Informations de copyright

Copyright: © 2022 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

Francesco Bedogni is consultant for Medtronic, Abbott, and Boston Scientific; Nedy Brambilla and Luca Testa are consultants for Abbott and Boston Scientific. The other authors declare no conflict of interest.

Auteurs

Riccardo Gorla (R)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Omar A Oliva (OA)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Enrico Poletti (E)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Alice Finotello (A)

Department of Civil Engineering and Architecture, University of Pavia, 27100 Pavia, Italy.

Simone Morganti (S)

Department of Electrical, Computer and Biomedical Engineering, University of Pavia, 27100 Pavia, Italy.

Jessica Zannoni (J)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Mauro Agnifili (M)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Marta Barletta (M)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Mattia Squillace (M)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Enrico Criscione (E)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Maurizio Tusa (M)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Nedy Brambilla (N)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Ferdinando Auricchio (F)

Department of Civil Engineering and Architecture, University of Pavia, 27100 Pavia, Italy.

Luca Testa (L)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Francesco Bedogni (F)

Department of Clinical and Interventional Cardiology, IRCCS Policlinico San Donato, 20097 San Donato Milanese (MI), Italy.

Classifications MeSH